Use of circulating tumor DNA analysis to predict recurrence and need for adjuvant chemotherapy in stage I-IV colorectal cancer.

作者
Li Li,Wenhua Fan,Zhiyuan Xia,Rongrong Chen,Dagui Lin,Fang Li,Yang Zheng,Jiongyong Luo,Yuanyuan Xiong,Pengli Yu,Wei Gao,Yuhua Gong,Sen Zhang,Feiran Zhang
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:41 (16_suppl): e15537-e15537
标识
DOI:10.1200/jco.2023.41.16_suppl.e15537
摘要

e15537 Background: Circulating tumor DNA (ctDNA) has emerged as a biomarker that can define the risk of recurrence after curative-intent surgery for patients with colorectal cancer (CRC). However, beyond the predictive power of postoperative ctDNA detection, the efficacy and potential limitations of ctDNA detection urgently need to be fully elucidated in a large cohort of CRC. Methods: We enrolled 309 patients with stages Ⅰ to Ⅳ CRC who underwent definitive surgery. Tumor tissues from those patients were sequenced by a custom-designed next-generation sequencing (NGS) panel to identify somatic mutations, and plasma was analyzed using ctDNA-based molecular residual disease (MRD) assay which integrated tumor genotype–informed and tumor genotype–naïve ctDNA analysis. Results: ctDNA was detected after surgery in 5.4%, 13.8%, 15% and 30% of patients with stage Ⅰ, Ⅱ, Ⅲ and Ⅳ disease, respectively, and in 17.5% of all longitudinal samples. Detection of MRD after surgery and in serial plasma samples during follow-up were associated with shorter disease-free survival (DFS) (hazard ratio [HR], 13.17; P < 0.0001 and HR, 14.44; P < 0.0001, respectively) independent of tumor site, stage, and MSI status. Within the population, only 13 patients (6.6%) with longitudinal undetectable MRD recurred, resulting in a negative predictive value of 93.4%. Correspondingly, the positive predictive value of longitudinal detectable MRD was 79.6%, with a median lead time of 10.1 months. Further subgroup analyses revealed that adjuvant therapy did not confer a superior survival for patients with undetectable or detectable MRD. Moreover, lung-only and peritoneal metastases were less detectable by MRD. Conclusions: Postoperative ctDNA status is a strong predictor of recurrence independent of stage and MSI status. Longitudinal undetectable MRD could be used to define the potentially cured population in CRC patients undergoing curative-intent surgery.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
充电宝的应助被cm采纳,获得10
2秒前
3秒前
4秒前
GIN的应助被Reaper采纳,获得10
5秒前
陈攀完成签到,获得积分10
7秒前
7秒前
二三发布了新的文献求助10
7秒前
ding的应助被JH_Yang采纳,获得10
7秒前
112完成签到 ,获得积分10
7秒前
思源的应助被嘻嘻哈哈顺利采纳,获得30
9秒前
zgm完成签到,获得积分10
9秒前
9秒前
王人捷发布了新的文献求助30
11秒前
搜集达人的应助被追寻夏槐采纳,获得20
11秒前
BIGDUCK完成签到,获得积分10
12秒前
FashionBoy的应助被vc采纳,获得10
12秒前
13秒前
14秒前
GG酱发布了新的文献求助30
14秒前
酷波er的应助被眼睛大初之采纳,获得10
15秒前
16秒前
田様的应助被鹦鹉采纳,获得10
16秒前
黄橙橙完成签到 ,获得积分10
17秒前
17秒前
syvshc的应助被含蓄的冰绿采纳,获得10
18秒前
lucky完成签到 ,获得积分10
19秒前
19秒前
20秒前
Ferry完成签到,获得积分10
21秒前
21秒前
JH_Yang发布了新的文献求助10
22秒前
Nole的应助被hannah采纳,获得10
23秒前
zZZZ发布了新的文献求助10
24秒前
24秒前
Ryan发布了新的文献求助10
24秒前
25秒前
西红柿发布了新的文献求助10
25秒前
123发布了新的文献求助10
25秒前
欢呼半山完成签到 ,获得积分10
25秒前
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192776
求助须知:如何正确求助?哪些是违规求助? 9579206
关于积分的说明 21864151
捐赠科研通 7792348
什么是DOI,文献DOI怎么找? 3437041
关于科研通互助平台的介绍 2560633
邀请新用户注册赠送积分活动 2483916